What payment terms are accepted?

We accept T/T, LC, and D/P as terms of payment.

What is the lead time for delivery?

The average lead time is one month for both peak and off-peak seasons.

Medipharm 5% Glucose and 0.9% Sodium Chloride Injection IV Solution

Name: Medipharm 5% Glucose and 0.9% Sodium Chloride Injection IV Solution
Brand: Anhui Medipharm Co., Ltd.
SKU: 1996933711

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$0.19-0.25

30,000 bottles

Sample price:US$0.00/bottle.Request sample

Product profile

Customization

Available

Application

Human

Usage Mode

Model NO.

AMC15005-02

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Liquid

Type

Biological Products

Pharmaceutical Technology

Bp, USP or Cp

Shelf Life

3 Years

Specificatio

5%+0.9%, 500ml

Transport Package

1bottle/ Box, 30boxes/CTN

Specification

GMP

Trademark

MEDIPHARM/OEM

Origin

China

HS Code

3004909099

Production Capacity

100000ctns Per Month

Key features

Comprehensive Indications: Indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride.

Strict Quality Standards: Manufactured under GMP standards with BP, USP, or CP drug approval numbers.

Long Shelf Life: Provides a reliable 3-year shelf life for storage and distribution.

Customization Options: Offers full customization from designs, samples, and OEM services.

ISO Certified Management: Holds ISO45001:2018 and ISO14001 certifications for safety and environment.

Global Market Reach: Exports to South America, Southeast Asia, Middle East, Africa, and South Asia.

Experienced Exporter: 14 years of export experience with 80%-100% repeat buyer rate.

Flexible Payment Terms: Accepts T/T, LC, and D/P for international transactions.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.94h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.